UK-315716/UK-240455 Pfizer

Current Opinion in Investigational Drugs

Volumn 2, Issue 12, 2001, Pages 1737-1739

  Capelli, Anna Maria ^a   Micheli, Fabrizio ^a  

^a GSK   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; GLYCINE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UK 142455; UK 148475; UK 155261; UK 203368; UK 212189; UK 240255; UK 240455; UK 252287; UK 276919; UK 315716; UNCLASSIFIED DRUG;

BRAIN ISCHEMIA; CLINICAL TRIAL; DOSE RESPONSE; DRUG BINDING SITE; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; NONHUMAN; REVIEW; SIDE EFFECT; STROKE; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING;

ANIMALS; CLINICAL TRIALS, PHASE I; HUMANS; NEUROPROTECTIVE AGENTS; QUINOXALINES; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0035683086     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Glycine antagonists: Regulation of the NMDA receptor-channel complex by the strychnine-insensitive glycine site
2. Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man
3. The glycine site of the NMDA receptor - Five years on
4. The glycine site on the NMDA receptor: Structure-activity relationships and therapeutic potential
5. Glycine potentiates the NMDA response in cultured mouse brain neurons
6. Pharmacology of 5-chloro-7-trifluoromethyl-1,4-dihydro-2,3-quinoxalinedione: A novel systematically active ionotropic glutamate receptor antagonist
7. Novel 4-substituted 3-hydroxyquinolin-2-ones: Potent glycine site antagonists
8. Trends in Medicinal Chemistry, Charing Cross Hospital, London, UK
9. The glycine site on the NMDA receptor: Structure-activity relationships and possible therapeutic applications
10. Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes
11. Glycine-site antagonists and stroke
12. New Medicines from Heterocycles - Royal Society of Chemistry Meeting, London, UK
13. Glycine antagonists for the treatment of stroke: A literature survey (1997-1999)
14. Medicinal Chemistry in Eastern England - 11th Symposium
15. Protection against ischemic neuronal damage by drugs acting on excitatory neurotransmitters
16. New treatments for acute stroke
17. Drug development pipeline - UK-240455
18. Recent developments in glycine antagonists
19. Chiral Europe 2000, San Gorg Corinthia Hotel, St. Julians, Malta
20. Discovery of UK's-240,455 and 315,716: CNS penetrant glycine site NMDA receptor antagonists with potential utility in treating stroke
21. American Chemical Society 221st National Meeting - Overnight Report (Part V), San Diego, USA
22. Structure-activity relationships of 1,4-dihydro-(1H,4H)-quinoxaline-2,3-diones as N-methyl-D-aspartate (glycine site receptor antagonists. 1. Heterocyclic substituted 5-alkayl derivatives
23. Discovery of UKs-240,455 and 315,716: CNS penetrant glycine site NMDA receptor antagonists with potential utility in treating stroke
24. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system
25. Excitatory amino acid transmitters
26. Non-competitive NMDA antagonists, acting on the glycine site
27. Recent developments in glycine antagonists